TuHURA Biosciences (HURA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.76, -3.83% vs the prior close of $1.83.
- Volume 85.88K shares, 0.4x its 50-day average (light).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
HURA slides 3.8% to $1.76. Closed at $1.76, -3.83% vs the prior close of $1.83. Day range $1.76–$1.84, opened at $1.81.
HURA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HURA slides 3.8% to $1.76
- Closed at $1.76, -3.83% vs the prior close of $1.83. Day range $1.76–$1.84, opened at $1.81.
- Volume was 85.88K shares, 0.4x its 50-day average of 234.88K — lighter than usual.
- Price is -15.1% vs its 50-day average ($2.07) and -7.8% vs its 200-day average ($1.91).
- 52-week range $0.41–$3.43; today's close sits at 45% of that range, 48.7% below the 52-week high.
Oct 15, 2026 — HURA jumps 4.0% to $1.83
- Closed at $1.83, +3.98% vs the prior close of $1.76. Day range $1.74–$1.84, opened at $1.74.
- Volume was 86.40K shares, 0.4x its 50-day average of 235.81K — lighter than usual.
- Price is -12.0% vs its 50-day average ($2.08) and -3.9% vs its 200-day average ($1.90).
- 52-week range $0.41–$3.43; today's close sits at 47% of that range, 46.6% below the 52-week high.
Oct 14, 2026 — HURA dips 2.8% to $1.76, a 6-month low, 3 down days in a row
- Closed at $1.76, -2.76% vs the prior close of $1.81. Day range $1.71–$1.78, opened at $1.78.
- Volume was 145.00K shares, 0.6x its 50-day average of 236.90K.
- Price is -15.6% vs its 50-day average ($2.09) and -7.3% vs its 200-day average ($1.90).
- 52-week range $0.41–$3.43; today's close sits at 45% of that range, 48.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HURA slides 4.7% to $1.81, a 6-month low
- Closed at $1.81, -4.74% vs the prior close of $1.90. Day range $1.80–$1.91, opened at $1.91.
- Volume was 354.30K shares, 1.5x its 50-day average of 233.98K.
- Price is -13.5% vs its 50-day average ($2.09) and -4.4% vs its 200-day average ($1.89).
- 52-week range $0.41–$3.43; today's close sits at 46% of that range, 47.2% below the 52-week high.
Oct 12, 2026 — HURA slides 3.1% to $1.90
- Closed at $1.90, -3.06% vs the prior close of $1.96. Day range $1.89–$1.99, opened at $1.97.
- Volume was 170.30K shares, 0.7x its 50-day average of 233.43K.
- Price is -9.5% vs its 50-day average ($2.10) and +0.6% vs its 200-day average ($1.89).
- 52-week range $0.41–$3.43; today's close sits at 49% of that range, 44.6% below the 52-week high.
Oct 9, 2026 — HURA rises 1.6% to $1.96
- Closed at $1.96, +1.55% vs the prior close of $1.93. Day range $1.95–$1.99, opened at $1.95.
- Volume was 149.00K shares, 0.6x its 50-day average of 235.62K.
- Price is -6.8% vs its 50-day average ($2.10) and +4.1% vs its 200-day average ($1.88).
- 52-week range $0.41–$3.43; today's close sits at 51% of that range, 42.9% below the 52-week high.
Oct 8, 2026 — HURA dips 2.5% to $1.93
- Closed at $1.93, -2.53% vs the prior close of $1.98. Day range $1.89–$1.97, opened at $1.95.
- Volume was 316.20K shares, 1.4x its 50-day average of 234.02K.
- Price is -8.4% vs its 50-day average ($2.11) and +2.8% vs its 200-day average ($1.88).
- 52-week range $0.41–$3.43; today's close sits at 50% of that range, 43.7% below the 52-week high.
Oct 7, 2026 — HURA rises 1.5% to $1.98
- Closed at $1.98, +1.54% vs the prior close of $1.95. Day range $1.87–$2.00, opened at $1.91.
- Volume was 140.20K shares, 0.6x its 50-day average of 235.49K — lighter than usual.
- Price is -6.2% vs its 50-day average ($2.11) and +5.8% vs its 200-day average ($1.87).
- 52-week range $0.41–$3.43; today's close sits at 52% of that range, 42.3% below the 52-week high.
Oct 6, 2026 — HURA jumps 4.3% to $1.95
- Closed at $1.95, +4.28% vs the prior close of $1.87. Day range $1.87–$1.98, opened at $1.90.
- Volume was 181.70K shares, 0.8x its 50-day average of 234.34K.
- Price is -7.7% vs its 50-day average ($2.11) and +4.5% vs its 200-day average ($1.87).
- 52-week range $0.41–$3.43; today's close sits at 51% of that range, 43.1% below the 52-week high.
Oct 5, 2026 — HURA dips 2.1% to $1.87, a 3-month low, 3 down days in a row
- Closed at $1.87, -2.09% vs the prior close of $1.91. Day range $1.85–$1.94, opened at $1.94.
- Volume was 334.30K shares, 1.4x its 50-day average of 231.73K.
- Price is -11.7% vs its 50-day average ($2.12) and +0.5% vs its 200-day average ($1.86).
- 52-week range $0.41–$3.43; today's close sits at 48% of that range, 45.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — HURA slides 3.5% to $1.91, a 3-month low
- Closed at $1.91, -3.54% vs the prior close of $1.98. Day range $1.88–$2.05, opened at $2.00.
- Volume was 287.70K shares, 1.3x its 50-day average of 229.32K.
- Price is -10.0% vs its 50-day average ($2.12) and +2.9% vs its 200-day average ($1.86).
- 52-week range $0.41–$3.43; today's close sits at 50% of that range, 44.3% below the 52-week high.
HURA latest news & SEC filings
Every SEC filing by or about HURA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 17, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
- Item 5.07 — Reported shareholder vote results.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$9.22M (prior year -$9.52M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.14 (prior year -$0.21) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.03 — Took on a new material debt or financial obligation.
Jul 9, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jul 9, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Things to know before you trade HURA
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Apr 1, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.74% (largest 5.7%).
- Liquidity: about 221.66K shares (≈$390.12K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.76 vs a range of $0.41–$3.43 (45% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:35 on Oct 18, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Sep 24, 2026; 8-K Sep 17, 2026.
- Share count: 63.73M shares outstanding (Aug 11, 2026), +27.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HURA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.81 | 1.84 | 1.76 | 1.76 | 85.88K |
| Oct 15, 2026 | 1.74 | 1.84 | 1.74 | 1.83 | 86.40K |
| Oct 14, 2026 | 1.78 | 1.78 | 1.71 | 1.76 | 145.00K |
| Oct 13, 2026 | 1.91 | 1.91 | 1.80 | 1.81 | 354.30K |
| Oct 12, 2026 | 1.97 | 1.99 | 1.89 | 1.90 | 170.30K |
| Oct 9, 2026 | 1.95 | 1.99 | 1.95 | 1.96 | 149.00K |
| Oct 8, 2026 | 1.95 | 1.97 | 1.89 | 1.93 | 316.20K |
| Oct 7, 2026 | 1.91 | 2.00 | 1.87 | 1.98 | 140.20K |
| Oct 6, 2026 | 1.90 | 1.98 | 1.87 | 1.95 | 181.70K |
| Oct 5, 2026 | 1.94 | 1.94 | 1.85 | 1.87 | 334.30K |
| Oct 2, 2026 | 2.00 | 2.05 | 1.88 | 1.91 | 287.70K |
| Oct 1, 2026 | 2.09 | 2.10 | 1.97 | 1.98 | 273.60K |
| Sep 30, 2026 | 2.06 | 2.17 | 2.06 | 2.10 | 284.50K |
| Sep 29, 2026 | 2.08 | 2.12 | 2.04 | 2.07 | 231.00K |
| Sep 28, 2026 | 2.06 | 2.16 | 2.03 | 2.09 | 375.40K |
| Sep 25, 2026 | 2.14 | 2.15 | 2.05 | 2.10 | 149.30K |
| Sep 24, 2026 | 2.04 | 2.12 | 2.03 | 2.10 | 194.50K |
| Sep 23, 2026 | 2.10 | 2.10 | 2.04 | 2.05 | 185.00K |
| Sep 22, 2026 | 2.17 | 2.22 | 2.10 | 2.13 | 251.70K |
| Sep 21, 2026 | 2.06 | 2.19 | 2.06 | 2.18 | 237.20K |
About TuHURA Biosciences
TuHURA Biosciences (HURA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TAMPA, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1498382.
HURA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James A. Bianco | Chief Executive Officer | May 29, 2026 |
| Robert E. Hoffman | Director | Feb 17, 2026 |
| Alan List | Director | Feb 17, 2026 |
| James S J Manuso | Director | Feb 17, 2026 |
| George K Ng | Director | Feb 17, 2026 |
| Craig Tendler | Director | Feb 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James A. Bianco | Chief Executive Officer | May 29, 2026 |
| Dan Dearborn | Chief Financial Officer | Jan 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
HURA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-30.05M | -0.63 | $-27.63M |
| Dec 31, 2024 | $0 | $-21.68M | -1.21 | $-14.73M |
| Jun 30, 2024 | — | $-8.32M | — | $-7.18M |
| Dec 31, 2023 | $0 | $-29.32M | -2.47 | $-11.95M |
| Jun 30, 2023 | — | $-14.65M | — | $-11.87M |
Latest balance sheet: total assets $31.75M, total liabilities $13.25M, cash $995.98K (as of Jun 30, 2026).
HURA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $2.47 |
| May 15, 2026 | 8-K Item 2.02 (results) | $2.31 |
| Apr 1, 2026 | 8-K Item 2.02 (results) | $1.62 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $2.05 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.76 |
| May 15, 2025 | 8-K Item 2.02 (results) | $3.84 |
| Apr 1, 2025 | 8-K Item 2.02 (results) | $2.91 |
| Oct 21, 2024 | 8-K Item 2.02 (results) | $5.53 |
| Oct 8, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Feb 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HURA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.